HEALTH SERVICES: Provides relative to psychedelic-assisted therapy. (8/1/26) (EN INCREASE GF EX See Note)

Summary

The bill authorizes academic health centers to run clinical and trial‑enabling studies of substances that are mechanistically similar to psilocybin. It also requires these centers to provide information to local parishes and work with them to support patients who may enroll in such studies. The changes ensure studies occur on‑site in hospitals or clinics with proper liability coverage.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share